Inventor · disambiguated record
Raffaella Rossin
Also filed as: ROSSIN RAFFAELLA
12 granted patents·10 pending applications·93 citations·filing 2005–2023
90Inventor score
Files withTAGWORKS PHARMACEUTICALS B V14ROBILLARD MARC STEFAN4UNIV WASHINGTON2LUB JOHAN1ROSSIN RAFFAELLA1
Top patents by PatentIndex Score
22 records- 0192US10376594B2Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2015·Granted Aug 13, 2019·11 cites·25 claims
- 0291US9463256B2Pretargeting kit, method and agents used thereinLUB JOHAN·Filed 2011·Granted Oct 11, 2016·35 cites·11 claims
- 0387US9427482B2Agents for clearing biomolecules from circulationROSSIN RAFFAELLA·Filed 2011·Granted Aug 30, 2016·19 cites·10 claims
- 0486US9931408B2Bio-orthogonal drug activationROBILLARD MARC STEFAN·Filed 2012·Granted Apr 3, 2018·7 cites·27 claims
- 0585US10967069B2Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2019·Granted Apr 6, 2021·1 cites·34 claims
- 0685US2024091371A1Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2023·Application pending·0 cites
- 0784US8354093B2Cell permeable nanoconjugates of shell-crosslinked knedel (SCK) and peptide nucleic acids (“PNAs”) with uniquely expressed or over-expressed mRNA targeting sequences for early diagnosis and therapy of cancerUNIV WASHINGTON·Filed 2005·Granted Jan 15, 2013·6 cites·8 claims
- 0883US9913921B2Pretargeting kit for imaging or therapy comprising a trans-cyclooctene dienophile and a dieneROBILLARD MARC STEFAN·Filed 2012·Granted Mar 13, 2018·11 cites·4 claims
- 0981US10927139B2Chemically cleavable groupTAGWORKS PHARMACEUTICALS B V·Filed 2013·Granted Feb 23, 2021·2 cites·37 claims
- 1076US11857636B2Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2021·Granted Jan 2, 2024·0 cites·17 claims
- 1173US11617799B2Cleavable tetrazine used in bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2017·Granted Apr 4, 2023·1 cites·41 claims
- 1267US12186405B2Cleavable tetrazine used in bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2022·Granted Jan 7, 2025·0 cites·33 claims
- 1363US2025114489A1Masked il12 proteinTAGWORKS PHARMACEUTICALS B V·Filed 2023·Application pending·0 cites
- 1460US2021002320A1Chemically cleavable groupTAGWORKS PHARMACEUTICALS B V·Filed 2020·Application pending·0 cites
- 1559US2022331458A1Agents for cleaving labels from biomolecules in vivoTAGWORKS PHARMACEUTICALS B V·Filed 2020·Application pending·0 cites
- 1656US9095601B2Cell permeable nanoconjugates of shell-crosslinked knedel (SCK) and peptide nucleic acids (“PNAs”) with uniquely expressed or over-expressed mRNA targeting sequences for early diagnosis and therapy of cancerUNIV WASHINGTON·Filed 2012·Granted Aug 4, 2015·0 cites·17 claims
- 1751US2021308207A1Compounds comprising a linker for increasing transcyclooctene stabilityTAGWORKS PHARMACEUTICALS B V·Filed 2019·Application pending·0 cites
- 1849US2022356169A1Tetrazines for high click release speed and yieldTAGWORKS PHARMACEUTICALS B V·Filed 2020·Application pending·0 cites
- 1947US2023121556A1Compounds for fast and efficient click releaseTAGWORKS PHARMACEUTICALS B V·Filed 2020·Application pending·0 cites
- 2046US2021299286A1Tetrazines for high click conjugation yield in vivo and high click release yieldTAGWORKS PHARMACEUTICALS B V·Filed 2019·Application pending·0 cites
- 2140US2012039803A1Pretargeting kit, method and agents used thereinROBILLARD MARC STEFAN·Filed 2010·Application pending·0 cites
- 2236US2012034161A1Pretargeting kit, method and agents used thereinROBILLARD MARC STEFAN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Raffaella Rossin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →